GlassScriptPhysician profile
Vishad Sukul
NPI 1194985192
$26,618.00
in general payments reported to CMS, 2019-2025
19 companies · $2,017 in 2025
The $2,017 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,663 · 2020: $4,384 · 2021: $1,456 · 2022: $2,133 · 2023: $2,344 · 2024: $7,621 · 2025: $2,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,466 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,225 · Travel and Lodging: $891 · Consulting Fee: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,465.58 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,225.00 |
| Travel and Lodging | $890.77 |
| Consulting Fee | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $9,697.90 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Dbs |
| Medtronic, INC. | $7,240.23 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Medtronic USA, INC. | $3,943.61 | 2019-2020 | |
| Neuropace, INC. | $2,328.68 | 2022-2025 | |
| Abbott Laboratories | $1,456.82 | 2019-2025 | Infinity, Proclaim, Axium |
| Monteris Medical Corporation | $584.51 | 2022-2024 | Neuroblate |
| Nevro Corp. | $393.77 | 2019-2022 | |
| Si-Bone, INC. | $239.93 | 2019-2023 | |
| Saluda Medical Americas, INC. | $195.89 | 2024-2025 | Evoke |
| Neurelis, INC. | $121.86 | 2025 | Valtoco |
| Jazz Pharmaceuticals INC. | $116.00 | 2022 | |
| Ucb, INC. | $104.62 | 2024 | |
| Livanova USA, INC. | $48.96 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Zimmer Biomet Holdings, INC. | $36.22 | 2022 | |
| Nalu Medical, INC. | $32.91 | 2022-2025 | Nalu Neurostimulation System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $27.82 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $21.43 | 2025 | Belbuca |
| Insightec,INC | $14.07 | 2023 | Exablate |
| Pfizer INC. | $12.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vishad Sukul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.